Catch canine osteoarthritis (OA) at its earliest stages with the innovative OA staging tool.
An Interactive Diagnosis
COAST is an innovative canine OA staging tool designed by a consortium of international experts in veterinary surgery and pain management. With COAST, you can start the conversation about canine OA with pet owners before it sets in, and monitor OA over time.
A Standardized Approach to Canine OA Diagnosis
Canine OA often goes unnoticed. In its early and mild stages, the signs are so subtle that it’s not always easy to identify that a dog is suffering from canine OA, especially in your clinic.
At home, dogs are more relaxed and more likely to show subtle changes in behavior that their owners can pick up on. It’s important every pet owner knows what to look out for, to help you with early diagnosis and intervention.
Using COAST in Your Clinic
With a simple, three-step process, including the tool as part of your daily clinical routine is easy.
Grade the Dog
Assess the dog’s overall level of discomfort and posture while stationary and in motion, with input from the pet owner about your patient’s behavior at home
Grade the Joint
Determine how much pain there is on manipulation, assess range of movement and take radiographs
COAST incorporates pet owner input from any appropriate clinical metrology instrument (CMI). The Liverpool Osteoarthritis in Dogs Index (LOAD), developed by the University of Liverpool and exclusively distributed by Elanco, is regarded as one of the most comprehensively validated CMIs for canine OA.2-5
Galliprant is an NSAID that controls pain and inflammation associated with osteoarthritis in dogs.
Important Safety Information
Not for use in humans. For use in dogs only. Keep this and all medications out of reach of children and pets. Store out of reach of dogs and other pets in a secured location in order to prevent accidental ingestion or overdose. Do not use in dogs that have a hypersensitivity to grapiprant. If Galliprant is used long term, appropriate monitoring is recommended. Concomitant use of Galliprant with other anti-inflammatory drugs, such as COX-inhibiting NSAIDs or corticosteroids, should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. The most common adverse reactions were vomiting, diarrhea, decreased appetite, and lethargy. Click here for full prescribing information.
Contact your Elanco or distributor representative, or call Elanco (1-888-545-5973) to discover how you can incorporate Galliprant into your canine OA protocol today.
1 Cachon T, Frykman O, Innes J, et al. Face validity of a proposed tool for staging canine osteoarthritis: Canine OsteoArthritis Staging Tool (COAST). Vet J. 2018;235:1-8.
2 Hercock CA, Pinchbeck G, Giejda A, Clegg PD, Innes JF. Validation of a client based clinical metrology instrument for the evaluation of canine elbow osteoarthritis. Journal of Small Animal Practice. 2009;50(6):266-71.
3 Muller C, Gaines B, Gruen M, Case B, Arrufat K, Innes J, Lascelles BD. Evaluation of clinical metrology instrument in dogs with osteoarthritis. Journal of veterinary internal medicine. 2016;30(3):836-46.
4 Walton MB, Cowderoy E, Lascelles D, Innes JF. Evaluation of construct and criterion validity for the ‘Liverpool Osteoarthritis in Dogs’(LOAD) clinical metrology instrument and comparison to two other instruments. PLoS One. 2013;8(3):e58125.
5 Walton B, Cox T, Innes J. ‘How do I know my animal got better?' - measuring outcomes in small animal orthopaedics. In Practice. 2018;40(2):42-50.
6 Epstein ME. Managing chronic pain in dogs and cats. Today’s Vet Pract. 2013;20-3.